Moderna

Moderna will construct a state-of-the-art manufacturing facility in Canada in order to provide direct access to mRNA vaccines for the Covid-19 pandemic, as well as future viral threats and respiratory viruses. 

An experimental monoclonal antibody developed at the U.S. National Institutes of Health (NIH) prevented malaria for up to nine months in volunteers exposed to the disease-causing parasite in a small trial, researchers reported on Aug. 11 in the New England Journal of Medicine.

Moderna, COVID-19 vaccine

Moderna Inc. is planning to double the size of an ongoing trial testing the company’s Covid-19 vaccines in children aged 6 months to less than 12 years.

Global biopharmaceutical firms Santen and Sydnexis entered an exclusive licensing deal for a drug formulation that aims to treat progressive myopia.

Inovio Pharmaceuticals Inc. is focused on launching the global late-stage trial of the company’s Covid-19 vaccine candidate in September 2021, chief executive Joseph Kim said in a call, with the drug developer expecting trial data in the first half of 2022.

Philip Morris continues to expand the tobacco giant’s ‘Beyond Nicotine’ strategy by acquiring Michigan-based OtiTopic, a company developing inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction.

The U.S. Food and Drug Administration issued a Complete Response Letter (CRL) to Henderson, Nev.-based Spectrum Pharmaceuticals.

Daiichi Sankyo and AstraZeneca reported positive topline data from their head-to-head DESTINY-Breast-03 Phase III trial for Enhertu versus trastuzumab emtansine (T-DM1) in patients with HER2 positive metastatic breast cancer.

In a review of recently published scientific studies, investigators at Keck School of Medicine of USC identified a natural barrier to the inner’s sensory cells’ ability to regenerate.

The U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients 1 year of age and older with late-onset Pompe disease, a progressive and debilitating muscle disorder that impairs a person’s ability to move and breathe.